United States securities and exchange commission logo





                             June 17, 2021

       Felipe MacLean
       President and Chief Executive Officer
       Clover Leaf Capital Corp.
       c/o Yntegra Capital Investments, LLC
       1450 Brickell Avenue, Suite 2520
       Miami, FL 33131

                                                        Re: Clover Leaf Capital
Corp.
                                                            Amendment No. 1 to
Registration Statement on Form S-1
                                                            Filed June 7, 2021
                                                            File No. 333-255111

       Dear Mr. MacLean:

             We have reviewed your amended registration statement and have the
following
       comments. In some of our comments, we may ask you to provide us with
information so we
       may better understand your disclosure.

              Please respond to this letter by amending your registration
statement and providing the
       requested information. If you do not believe our comments apply to your
facts and
       circumstances or do not believe an amendment is appropriate, please tell
us why in your
       response.

              After reviewing any amendment to your registration statement and
the information you
       provide in response to these comments, we may have additional comments.

       Amendment No. 1 to Registration Statement on Form S-1

       The Offering, page 18

   1.                                                   We note your disclosure
that if no public stockholders redeem their Class A common
                                                        stock in connection
with your initial business combination, each public stockholder will
                                                        receive one-fifteenth
(1/15) of a share of Class A common stock. Please revise to clarify
                                                        here and throughout
your prospectus, if true, that the distributable shares will be
                                                        distributed to holders
of Class A common stock at a ratio of 1/15 of a share of Class A
                                                        common stock for each
share of Class A common stock they beneficially own.
 Felipe MacLean
FirstName
Clover LeafLastNameFelipe
            Capital Corp. MacLean
Comapany
June       NameClover Leaf Capital Corp.
     17, 2021
June 17,
Page 2 2021 Page 2
FirstName LastName
Description of Securities
Rights, page 151

2.       We note your disclosure that with respect to the detachable rights and
contingent rights
         that you will either round up a fractional interest in your Class A
shares or otherwise
         address such fractional interest    in accordance with the applicable
provisions of Delaware
         Law.    You also state that there are no contractual penalties for
failure to deliver securities
         to the holders of the rights upon consummation of the initial business
combination.
         Further, you state that in no event will you be required to net cash
settle the detachable
         rights and shareholders might not receive the shares of Class A common
stock underlying
         the rights.

         Please revise to clearly disclose how you may treat fractional
interests rather than
         referring generally to the requirements of Delaware Law. Additionally,
please tell us the
         basis for your conclusion you would not be liable to the holders of
rights for failure to
         deliver securities underlying the rights.
Notes to the Financial Statements
Note 8. Subsequent Events, page F-16

3.       We note your disclosure that you re-evaluated the deal structure and
removed the
         warrants, and replaced it with (i) one right to receive one-
         one-twentieth (1/20) of a share of Class A common stock upon the
consummation of an
         initial business combination (the    detachable rights   ), and (ii) a
contingent right to receive
         one-fifteenth (1/15) of a share of Class A common stock following the
initial business
         combination redemption time under certain circumstances pursuant to
your contingent
         rights agreement, and subject to adjustment (the    contingent rights
 ). Please tell us how
         you intend to account for the detachable rights and the contingent
rights, and specifically
         discuss how you considered the guidance under ASC 480, ASC 815-10 and
ASC 815-40.
         Additionally, please clarify the terms of the contingent rights that
are    subject to
         adjustment    and explain whether those same terms are subject to
adjustment in the
         detachable rights.
 Felipe MacLean
Clover Leaf Capital Corp.
June 17, 2021
Page 3

       You may contact Christine Torney at 202-551-3652 or Lynn Dicker at
202-551-3616 if
you have questions regarding comments on the financial statements and related
matters. Please
contact Abby Adams at 202-551-6902 or Christine Westbrook at 202-551-5019 with
any other
questions.



                                                          Sincerely,
FirstName LastNameFelipe MacLean
                                                          Division of
Corporation Finance
Comapany NameClover Leaf Capital Corp.
                                                          Office of Life
Sciences
June 17, 2021 Page 3
cc:       Jessica S. Yuan, Esq.
FirstName LastName